On 5 July, Reuters reported that Chinese pharma company Wuxi Biologics, one of 33 companies put on the US Unverified List in February this year, was able to participate in end-user inspections conducted by a US export control officer in China.
China has had strict travel restrictions both internally and from outside the country since the pandemic began. Wuxi Biologics and the other companies put on the Unverified List were unable to accept inspections, including end-user checks, due ...
Continue reading
SUBSCRIBED FEATURES
- Export Compliance Manager Tackles the issues and challenges that keep trade compliance professionals awake at night... with insight and with solutions.
- Export Compliance Manager Shares the know-how of experienced professionals, keeping its readers on top of developing best practice in trade compliance AND helping to deliver real commercial advantage.
- Export Compliance Manager Celebrates the valuable contribution of trade compliance professionals to their companies, communities and to international security.
